Ameriprise’s Nutraceutical International Co NUTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-22,554
Closed -$940K 3832
2017
Q2
$940K Sell
22,554
-40,028
-64% -$1.43M ﹤0.01% 2972
2017
Q1
$1.95M Sell
62,582
-4,144
-6% -$140K ﹤0.01% 2587
2016
Q4
$2.33M Sell
66,726
-8,526
-11% -$270K ﹤0.01% 2550
2016
Q3
$2.35M Buy
+75,252
New +$1.94M ﹤0.01% 2483
2014
Q4
Sell
-1
Closed 4889
2014
Q3
$0 Hold
1
﹤0.01% 5975
2014
Q2
$0 Sell
1
-30
-97% -$737 ﹤0.01% 5743
2014
Q1
$1K Buy
31
+30
+3,000% +$778 ﹤0.01% 5229
2013
Q4
$0 Sell
1
-563
-100% -$14K ﹤0.01% 5599
2013
Q3
$14K Sell
564
-49
-8% -$1.11K ﹤0.01% 4677
2013
Q2
$13K Buy
+613
New +$11.6K ﹤0.01% 4609

Ameriprise's NUTR Position: Q3 2017 in Review

Ameriprise sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 22,554 shares — an estimated $940K sold.

Ameriprise first reported a position in NUTR in Q2 2013 and held it in 10 quarters. The position peaked at $2.35M in Q3 2016. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.

  • Ameriprise reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
  • Ameriprise sold 22,554 Nutraceutical International Co shares in Q3 2017, an estimated $940K.
  • Ameriprise first reported a position in Nutraceutical International Co in Q2 2013 and held it in 10 quarters.
  • Ameriprise's Nutraceutical International Co position peaked at $2.35M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.

Based on Ameriprise's 13F filing for Q3 2017, filed 7 Nov 2017.